🔗 Permalink

Inventor profile of:

Richard KROCZEK

City:

Berlin

Country:

Germany

Published Applications:

Last publication date:

2022-03-10

Top Assignees for applications by Richard KROCZEK

The entities that hold a legal rights for patent applications filed by inventor KROCZEK Richard:

Bundesrepublik Deutschland letztvertreten durch das Robert-Koch-Institut vertreten durch seinen Präsidenten 2 Berlin, Germany
Bundersrepublik Deutschland 2 Berlin, Germany
BUNDESREPUBLIK DEUTSCHLAND LETZVERTRETEN DURCH DAS ROBERT KOCH-INSTITUT VERTRETEN DURCH SEINEN PRAESIDENTEN 1 Berlin, Germany
Bundersrepublik Deutschland Letztvertreten Durch Den Direktor Des Robert-Koch-Institutes 1 Berlin, Germany
Bundersrepubik Deutschland Letztvertreten Durch Den Direktor Des Robert-Koch-Institutes 1 Berlin, Germany
BUNDESREPUBLIK DEUTSCHLAND LETZTVERTRETEN DURCH DAS ROBERT-KOCH-INSTITUT VERTRETEN DURCH SEINEN PRÄSIDENTEN 1 Berlin, Germany
Bundesrepublik Deutschland letztvertreten durch das Robert Koch-Institut vertreten durch seinen 1 Berlin, Germany
Bundesrepublik Deutschland letztvertreten durch das Robl Koch-Institut vertreten durch seinen Präsidenten 1 Berlin, Germany
Bundersrepublik Deutschalnd 1 Berlin, Germany
Bundersrespublik Deutschaland Letztvertreten Durch Den Direktor Des Robert-Koch-Institutes 1 Berlin, Germany
Bundesrepublik Deutschland letztvertreten durch das Robert- Koch-lnstitut vertreten durch seinen 1 Berlin, Germany

Recent patent applications by KROCZEK Richard

Richard KROCZEK from Berlin, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-03-10

US20220073630A1

Chemistry; metallurgy

A PEPTIDE-MHC-I-ANTIBODY FUSION PROTEIN FOR THERAPEUTIC USE IN A PATIENT WITH AMPLIFIED IMMUNE RESPONSE

#2 | 2021-03-18

US20210077601A1

Human necessities

Medicament for use in a method of inducing or extending a cellular cytotoxic immune response

#3 | 2017-03-30

US20170087232A1

Human necessities

Medicament for use in a method of inducing or extending a cellular cytotoxic immune response

#4 | 2017-03-23

US20170080067A1

Human necessities

Medicament for use in a method of inducing or extending a cellular cytotoxic immune response

#5 | 2013-09-19

US20130245236A1

Chemistry; metallurgy

ANTIBODIES TO THE CHEMOKINE RECEPTOR XCR1

#6 | 2013-03-07

US20130058868A1

Chemistry; metallurgy

Method for the treatment of T cell mediated conditions by depletion of ICOS-positive cells in vivo

#7 | 2012-02-23

US20120045447A1

Chemistry; metallurgy

T CELL COSTIMULATING POLYPEPTIDES AND USES THEREOF

#8 | 2012-02-16

US20120039902A1

Chemistry; metallurgy

Antibodies for depletion of ICOS-positive cells in vivo

#9 | 2010-12-09

US20100310562A1

Chemistry; metallurgy

System for delivery into XCR1 positive cell and uses thereof

#10 | 2009-03-19

US20090074784A1

Chemistry; metallurgy

Treatment of chronic viral diseases with antibodies to costimulating polypeptide of T cells

#11 | 2008-11-20

US20080286283A1

Chemistry; metallurgy

Treatment of cancer with antibodies to costimulating polypeptide of T cells

#12 | 2008-05-22

US20080118513A1

Chemistry; metallurgy

Treatment of immune disorders with antibodies to costimulating polypeptide of T cells

#13 | 2007-08-21

US9509283

Anti-human T-cell costimulating polypeptide monoclonal antibodies

#14 | 2006-11-07

US9823307

Methods of modulating T lymphocyte costimulation with an antibody to an 8F4 polypeptide

#15 | 2006-10-24

US9972524

Methods for treatment of asthmatic disorders using a monoclonal antibody to 8F4 polypeptide

#16 | 2005-11-24

US20050261489A1

Chemistry; metallurgy

Treatment of autoimmune disorders with antibodies to costimulating polypeptide of T cells

InventorID:

126702 ⎘